Sargramostim (GM-CSF) + PD-1

Clinical trial NCT04703426 · WITHDRAWN

Trial details

NCT number: NCT04703426
Sponsor: Dana-Farber Cancer Institute
Status: WITHDRAWN
Phase: Phase 2
Study type: INTERVENTIONAL

Unresectable Melanoma Metastatic Melanoma Stage III Melanoma Stage IV Melanoma

Start date: 2021-04-16
Primary completion: 2024-06-10
Enrollment: 0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.